Patents Assigned to Aptorum Therapeutics Limited
  • Publication number: 20220023297
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Application
    Filed: October 5, 2021
    Publication date: January 27, 2022
    Applicant: Aptorum Therapeutics Limited
    Inventors: Wai Yip Thomas LEE, Chung Sing Daniel POON, Ka Lun LAI, Junzhe HUANG, Ho Yin LI
  • Patent number: 11166952
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Grant
    Filed: November 27, 2020
    Date of Patent: November 9, 2021
    Assignee: APTORUM THERAPEUTICS LIMITED
    Inventors: Wai Yip Thomas Lee, Chung Sing Daniel Poon, Ka Lun Lai, Junzhe Huang, Ho Yin Li
  • Publication number: 20210161892
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Application
    Filed: November 27, 2020
    Publication date: June 3, 2021
    Applicant: Aptorum Therapeutics Limited
    Inventors: Wai Yip Thomas LEE, Chung Sing Daniel POON, Ka Lun LAI, Junzhe HUANG, Ho Yin LI